Koninklijke Philips (NYSE:PHG) Receives Average Rating of "Hold" from Brokerages

Koninklijke Philips (NYSE:PHG - Get Free Report) has earned a consensus recommendation of "Hold" from the five analysts that are covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company.

Several analysts have weighed in on the company. Jefferies Financial Group raised Koninklijke Philips from an "underperform" rating to a "hold" rating in a report on Tuesday. StockNews.com raised shares of Koninklijke Philips from a "hold" rating to a "buy" rating in a research note on Monday, July 15th.

Koninklijke Philips Price Performance

Shares of PHG stock traded up $0.22 during trading hours on Tuesday, reaching $26.84. 2,104,995 shares of the company were exchanged, compared to its average volume of 983,390. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The company has a market cap of $25.23 billion, a price-to-earnings ratio of -50.58, a P/E/G ratio of 1.04 and a beta of 0.74. The stock's fifty day moving average is $31.05 and its two-hundred day moving average is $27.83. Koninklijke Philips has a fifty-two week low of $18.47 and a fifty-two week high of $32.91.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its earnings results on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. The company had revenue of $4.80 billion during the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. Sell-side analysts forecast that Koninklijke Philips will post 1.59 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Koninklijke Philips

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mondrian Investment Partners LTD raised its holdings in Koninklijke Philips by 45.1% during the 1st quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company's stock worth $191,061,000 after buying an additional 2,971,008 shares during the period. Millennium Management LLC boosted its holdings in shares of Koninklijke Philips by 822.0% in the 2nd quarter. Millennium Management LLC now owns 1,120,521 shares of the technology company's stock valued at $28,237,000 after buying an additional 998,995 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Koninklijke Philips by 27.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company's stock valued at $101,718,000 after acquiring an additional 864,951 shares during the period. Jane Street Group LLC increased its stake in shares of Koninklijke Philips by 361.7% during the 1st quarter. Jane Street Group LLC now owns 629,136 shares of the technology company's stock worth $12,583,000 after purchasing an additional 492,881 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its holdings in shares of Koninklijke Philips by 36.4% in the 1st quarter. Russell Investments Group Ltd. now owns 1,410,067 shares of the technology company's stock valued at $28,201,000 after purchasing an additional 376,244 shares during the period. Institutional investors own 13.67% of the company's stock.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.